CD274 and neoplasm: In multivariate analysis, baseline sCombo positivity was independently associated with a shorter PFS (HR: 2.66, (1.17–6.08), p = 0.02) whereas tumor PD-L1 expression was not (HR: 0.99 (0.98–1.00) p = 0.051).